why choose us

First received: March 01, 2023

Clinical Trial: ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Knee Osteoarthritis

Study Type: INTERVENTIONAL


Official Title: ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial

Brief Summary: This study is a prospective, multicenter (up to 4 sites), randomized, double-blind, two-arm study.Forty-five (45) patients will be randomized to receive a single 4-6 ml intra-articular (IA) injection of either the output of ACP Max™ (n=30) or 6 ml of Depo-Medrol® (methylprednisolone acetate) (n=15).

Read more